Nahdi Medical Company (TADAWUL:4164)

Nahdi Medical Company Balance Sheet

Financials in millions SAR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	143.68	554.44	956.81	909.66	1,076	401.04
Cash & Short-Term Investments	510.65	554.44	956.81	909.66	1,076	401.04
Cash Growth	-26.19%	-42.05%	5.18%	-15.48%	168.38%	-60.24%
Accounts Receivable	312.31	262.89	135.5	172.85	130.2	140.28
Receivables	312.31	262.89	135.5	172.85	178.61	185.61
Inventory	2,161	2,278	1,711	1,409	1,183	1,116
Prepaid Expenses	291.83	108.14	93.74	92.65	47.47	48.35
Other Current Assets	-	95.68	196.69	163.62	78.42	47.89
Total Current Assets	3,275	3,299	3,094	2,748	2,564	1,799
Property, Plant & Equipment	2,979	3,028	2,720	2,307	2,080	2,213
Other Intangible Assets	66.12	67.62	68.62	51.17	47.06	44.21
Long-Term Accounts Receivable	16.77	10.63	-	-	-	-
Other Long-Term Assets	276.61	285.37	291.57	264.86	253.81	230.09
Total Assets	6,814	6,691	6,173	5,371	4,945	4,287

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1,479	1,419	1,233	894.31	637.17	484
Accrued Expenses	633.31	222.86	272.32	288.98	348.45	213.33
Current Portion of Leases	416.62	420.24	383.48	304.19	375.87	367.42
Current Income Taxes Payable	29.19	50.71	76.97	112.53	106.55	96.87
Current Unearned Revenue	-	24.91	20.84	4.33	13	18.18
Other Current Liabilities	-	10.22	19.62	26.76	27.35	106.06
Total Current Liabilities	2,558	2,148	2,006	1,631	1,508	1,286
Long-Term Leases	1,340	1,363	1,146	870.57	792.23	991.64
Pension & Post-Retirement Benefits	392.97	421.46	420.49	392.12	380.86	386.73
Other Long-Term Liabilities	11.13	15.24	14.62	14.79	20.04	19.09
Total Liabilities	4,302	3,947	3,587	2,909	2,702	2,683

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	1,300	1,300	1,300	1,300	1,300	1,300
Retained Earnings	1,211	1,443	1,286	1,164	943.78	303.78
Comprehensive Income & Other	0.2	0.11	-0.07	-0.84	-0.39	-0.18
Shareholders' Equity	2,512	2,744	2,586	2,463	2,243	1,604
Total Liabilities & Equity	6,814	6,691	6,173	5,371	4,945	4,287

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	1,756	1,783	1,530	1,175	1,168	1,359
Net Cash (Debt)	-1,246	-1,229	-572.95	-265.09	-91.79	-958.01
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-9.58	-9.45	-4.41	-2.04	-0.71	-7.37
Filing Date Shares Outstanding	130	130	130	130	130	130
Total Common Shares Outstanding	130	130	130	130	130	130
Working Capital	717.18	1,151	1,088	1,117	1,055	513.51
Book Value Per Share	19.32	21.10	19.89	18.94	17.26	12.34
Tangible Book Value	2,446	2,676	2,517	2,412	2,196	1,559
Tangible Book Value Per Share	18.81	20.58	19.37	18.55	16.89	12.00
Land	-	58.17	58.17	58.17	58.17	74.43
Buildings	-	291.95	281.3	252.24	246.59	44.42
Machinery	-	580.76	504.91	440.24	372.03	367.85
Construction In Progress	-	107.83	50.01	59.47	51.59	285.13
Leasehold Improvements	-	1,781	1,580	1,363	1,135	974.08

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 3, 2026

Data Sources Report a data error